Zyflamend Softgels

Suggested/Recommended/Usage/Directions

Suggested Use: One softgel two times daily. Take in the middle of a larger meal with an 8 oz. glass of water.

FDA Disclaimer Statement

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

General Statements: All Other Content

Clinically Tested and Doctor Recommended

General Statements: All Other Content

NC10

General Statements: All Other Content

Patent Number US 6, 387, 416 B1

General Statements: All Other Content

Printed with water based inks.

General Statements: All Other Content

The #1 Selling Herbal in the U.S.‡

Precautions re: Pregnant or Nursing or Prescription Medications

If you are nursing, pregnant, or considering pregnancy, you should consult your health care practitioner prior to using this product.

Brand IP Statement(s) re: (c), (TM), (SM)

‡ According to 2008 SPINS(R) Marketing Research

Brand IP Statement(s) re: (c), (TM), (SM)

New Chapter’s Supercritical Herbal Extracts “Supercritical” means Super Purity, Super Potency, Broad Spectrum, and No Chemical Solvents. A Supercritical New Chapter in Inflammation Modulation.* New Chapter’s patented Zyflamend(R) formulation represents a scientific breakthrough in promoting a healthy inflammation response.* Recent research studies suggest this may be an effective strategy to promote healthy joint function and normal cell growth.*

Formulation re: Does NOT Contain

Our premium softgel capsules are prepared without any chemical solvents and are prion free.

Precautions re: All Other

As with any dietary or herbal supplement, you should advise your health care practitioner of the use of this product.

Precautions re: All Other

Caution: New Chapter sells Zyflamend only as a dietary supplement, not as a drug product. Zyflamend is not promoted by New Chapter as a product for the prevention, treatment, mitigation, or cure of breast cancer, prostate cancer, or any other specific disease or class of diseases.

FDA Statement of Identity

DIETARY SUPPLEMENT